PubRank

Shiro Kamakura

Author PubWeight™ 119.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2009 4.99
2 Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007 2.88
3 Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction. Circulation 2006 2.72
4 Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009 2.65
5 UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin Pharmacol Ther 2004 2.14
6 Participation of a concealed atriohisian tract in the reentrant circuit of the slow-fast type of atrioventricular nodal reentrant tachycardia. Heart Rhythm 2007 2.03
7 Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. Heart Rhythm 2010 2.00
8 Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. J Am Coll Cardiol 2005 1.88
9 High prevalence of early repolarization in short QT syndrome. Heart Rhythm 2010 1.87
10 Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 2007 1.80
11 Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome. J Am Coll Cardiol 2010 1.78
12 Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization. Circ Arrhythm Electrophysiol 2011 1.74
13 Effect of sodium-channel blockade on early repolarization in inferior/lateral leads in patients with idiopathic ventricular fibrillation and Brugada syndrome. Heart Rhythm 2011 1.71
14 The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 2008 1.69
15 Catheter ablation of stable and unstable ventricular tachycardias in patients with arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2006 1.64
16 Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm 2008 1.64
17 Sex hormone and gender difference--role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol 2007 1.63
18 Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study). Europace 2010 1.63
19 Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol 2002 1.63
20 Unique electrophysiologic characteristics of atrioventricular nodal reentrant tachycardia with different ventriculoatrial block patterns: effects of slow pathway ablation and insights into the location of the reentrant circuit. Heart Rhythm 2006 1.59
21 Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J 2008 1.57
22 Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004 1.53
23 "Left-variant" atypical atrioventricular nodal reentrant tachycardia: electrophysiological characteristics and effect of slow pathway ablation within coronary sinus. J Cardiovasc Electrophysiol 2006 1.52
24 Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol 2004 1.51
25 Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome. J Cardiovasc Electrophysiol 2008 1.50
26 Significance of non-type 1 anterior early repolarization in patients with inferolateral early repolarization syndrome. J Am Coll Cardiol 2013 1.47
27 Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003 1.43
28 Impact of left ventricular diastolic dysfunction on outcome of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. Circ J 2014 1.43
29 KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders. Heart Rhythm 2009 1.43
30 Noninvasive characterization of intra-atrial reentrant tachyarrhythmias after surgical repair of congenital heart diseases. Circ J 2009 1.40
31 Relationship between oral amiodarone and inappropriate therapy from an implantable cardioverter defibrillator. Circ J 2010 1.40
32 Significant increase in the incidence of ventricular arrhythmic events after an intrathoracic impedance change measured with a cardiac resynchronization therapy defibrillator. Circ J 2011 1.39
33 The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002 1.39
34 Magnetocardiography study on ventricular depolarization-current pattern in patients with brugada syndrome and complete right-bundle branch blocks. Pacing Clin Electrophysiol 2006 1.39
35 Clinical effect of implantable cardioverter defibrillator replacements: when should you resume driving after an implantable cardioverter defibrillator replacement? Circ J 2010 1.39
36 Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 2003 1.35
37 Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 2008 1.24
38 Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan. Pharmacogenetics 2003 1.11
39 ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome. J Am Coll Cardiol 2002 1.10
40 QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy. Circ J 2009 1.04
41 Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population. Hum Mutat 2004 1.03
42 Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 2002 1.02
43 Mechanisms of disease: current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med 2005 1.00
44 Mutation site dependent variability of cardiac events in Japanese LQT2 form of congenital long-QT syndrome. Circ J 2008 0.99
45 Genetic variations and haplotypes of UGT1A4 in a Japanese population. Drug Metab Pharmacokinet 2005 0.97
46 Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome. Eur Heart J 2004 0.96
47 Initial experience using Excimer laser for the extraction of chronically implanted pacemaker and implantable cardioverter defibrillator leads in Japanese patients. J Cardiol 2013 0.95
48 Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome. Hum Mutat 2009 0.95
49 Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region. Drug Metab Dispos 2004 0.91
50 Seven novel single nucleotide polymorphisms in the human SLC22A1 gene encoding organic cation transporter 1 (OCT1). Drug Metab Pharmacokinet 2004 0.91
51 Efficacy of additional radiofrequency applications for spontaneous dissociated pulmonary vein activity after pulmonary vein isolation in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2013 0.90
52 Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome. Am J Cardiol 2006 0.90
53 Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing. Clin Chem 2003 0.90
54 Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population. Drug Metab Dispos 2004 0.89
55 Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Drug Metab Pharmacokinet 2005 0.88
56 Single nucleotide polymorphisms and haplotype frequencies of CYP3A5 in a Japanese population. Hum Mutat 2003 0.88
57 Electrocardiographic predictors of response to cardiac resynchronization therapy in patients with intraventricular conduction delay. Circ J 2013 0.87
58 Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. Circ J 2006 0.86
59 Two adults requiring implantable defibrillators because of ventricular tachycardia and left ventricular dysfunction caused by presumed Kawasaki disease. Circ J 2005 0.86
60 Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram. Heart Rhythm 2011 0.86
61 Sequence-based analysis of the CYP2D6*36-CYP2D6*10 tandem-type arrangement, a major CYP2D6*10 haplotype in the Japanese population. Drug Metab Pharmacokinet 2006 0.86
62 Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation. Heart Rhythm 2013 0.85
63 Response of beat-by-beat QT variability to sympathetic stimulation in the LQT1 form of congenital long QT syndrome. Heart Rhythm 2005 0.85
64 Effect of amiodarone on the serum concentration/dose ratio of metoprolol in patients with cardiac arrhythmia. Drug Metab Pharmacokinet 2006 0.85
65 Neurally mediated syncope as a cause of syncope in patients with Brugada electrocardiogram. J Cardiovasc Electrophysiol 2009 0.84
66 Genetic polymorphisms of UGT1A6 in a Japanese population. Drug Metab Pharmacokinet 2005 0.84
67 Lack of interaction between amiodarone and mexiletine in cardiac arrhythmia patients. J Clin Pharmacol 2002 0.83
68 Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Am J Cardiol 2007 0.83
69 Functional analysis of four naturally occurring variants of human constitutive androstane receptor. Mol Genet Metab 2005 0.83
70 Ventricular tachycardia associated with bidirectional reentrant circuit around the tricuspid annulus in arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol 2003 0.83
71 Eleven novel single nucleotide polymorphisms in the NR1I2 (PXR) gene, four of which induce non-synonymous amino acid alterations. Drug Metab Pharmacokinet 2002 0.82
72 Transplantation of mesenchymal stem cells improves atrioventricular conduction in a rat model of complete atrioventricular block. Cell Transplant 2008 0.82
73 Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2). Drug Metab Pharmacokinet 2004 0.81
74 Efficacy of hemodynamic-based management of tachyarrhythmia after repair of tetralogy of Fallot. Circ J 2012 0.81
75 Shifting of puncture site in the fossa ovalis during radiofrequency catheter ablation: intracardiac echocardiography-guided transseptal left heart catheterization. Jpn Heart J 2003 0.81
76 Clinical and Pathological Impact of Tissue Fibrosis on Lethal Arrhythmic Events in Hypertrophic Cardiomyopathy Patients With Impaired Systolic Function. Circ J 2015 0.81
77 Macroreentrant atrial flutter around a common atrioventricular canal in an infant with complicated congenital heart anomaly. Pacing Clin Electrophysiol 2002 0.81
78 Heart failure elevates serum levels of cibenzoline in arrhythmic patients. Circ J 2006 0.81
79 Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease. Circ J 2008 0.80
80 Extremely late pacemaker-infective endocarditis due to Stenotrophomonas maltophilia. Cardiology 2007 0.80
81 Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents. Circ J 2011 0.80
82 Beneficial effects of cilostazol in a patient with recurrent ventricular fibrillation associated with early repolarization syndrome. Heart Rhythm 2012 0.80
83 Five novel single nucleotide polymorphisms in the CYP2C8 gene, one of which induces a frame-shift. Drug Metab Pharmacokinet 2002 0.80
84 Classification and assessment of computerized diagnostic criteria for Brugada-type electrocardiograms. Heart Rhythm 2010 0.80
85 CYP2C8 haplotype structures and their influence on pharmacokinetics of paclitaxel in a Japanese population. Pharmacogenet Genomics 2007 0.80
86 Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes. J Pharmacol Exp Ther 2003 0.79
87 Cardiac resynchronization therapy to prevent life-threatening arrhythmias in patients with congestive heart failure. J Electrocardiol 2011 0.79
88 Investigation of the optimal treatment strategy for atrial fibrillation in Japan. Circ J 2003 0.78
89 Repolarization spatial-time current abnormalities in patients with coronary heart disease. Pacing Clin Electrophysiol 2009 0.78
90 Novel nonsynonymous single nucleotide polymorphisms in the CYP2D6 gene. Drug Metab Pharmacokinet 2004 0.78
91 Three novel single nucleotide polymorphisms in UGT1A9. Drug Metab Pharmacokinet 2003 0.78
92 Effect of protein binding of pilsicainide on the pharmacokinetics. Drug Metab Pharmacokinet 2005 0.78
93 Predictors of electrical storm in patients with idiopathic dilated cardiomyopathy--how to stratify the risk of electrical storm. Circ J 2010 0.78
94 Diverse structures of chimeric CYP-REP7/6-containing CYP2D6 and a novel defective CYP2D6 haplotype harboring single-type *36 and CYP-REP7/6 in Japanese. Drug Metab Pharmacokinet 2006 0.78
95 Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors. Circ J 2014 0.78
96 Implications of 2:1 atrioventricular block during typical atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol 2007 0.78
97 Genetic variations of the AHR gene encoding aryl hydrocarbon receptor in a Japanese population. Drug Metab Pharmacokinet 2004 0.77
98 Clinical characteristics and risk of arrhythmia recurrences in patients with idiopathic ventricular fibrillation associated with early repolarization. Int J Cardiol 2012 0.77
99 Twenty-six novel single nucleotide polymorphisms and their frequencies of the NR1I3 (CAR) gene in a Japanese population. Drug Metab Pharmacokinet 2003 0.77
100 Spatial distribution of repolarization and depolarization abnormalities evaluated by body surface potential mapping in patients with Brugada syndrome. Pacing Clin Electrophysiol 2006 0.77
101 Mechanism and new findings in Brugada syndrome. Circ J 2007 0.77
102 Reconstruction of action potential of repolarization in patients with congenital long-QT syndrome. Phys Med Biol 2004 0.77
103 Novel algorithm for quantitative assessment of left ventricular dyssynchrony with ECG-gated myocardial perfusion SPECT: useful technique for management of cardiac resynchronization therapy. Ann Nucl Med 2011 0.77
104 Detection of spatial repolarization abnormalities in patients with LQT1 and LQT2 forms of congenital long-QT syndrome. Physiol Meas 2002 0.77
105 Heart rate-dependent variability of cardiac events in type 2 congenital long-QT syndrome. Europace 2010 0.77
106 Intravenous administration of nifekalant hydrochloride for the prevention of ischemia-induced ventricular tachyarrhythmia in patients with renal failure undergoing hemodialysis. Circ J 2003 0.76
107 Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride. J Cardiovasc Pharmacol 2006 0.76
108 Seasonal and circadian distributions of cardiac events in genotyped patients with congenital long QT syndrome. Circ J 2012 0.76
109 Standard template of adult magnetocardiogram. Ann Noninvasive Electrocardiol 2008 0.76
110 The positional relationship between the coronary sinus musculature and the atrioventricular septal junction. Europace 2010 0.76
111 Subtraction magnetocardiogram for detecting coronary heart disease. Ann Noninvasive Electrocardiol 2010 0.76
112 Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations　- Long-Term Prognosis After Initiation of Medical Treatment. Circ J 2016 0.76
113 A simple and accurate method to identify early ventricular contraction sites in Wolff-Parkinson-White syndrome using high frame-rate tissue-velocity imaging. Am J Cardiol 2003 0.75
114 Radiofrequency catheter ablation of parasystole originating from the inferior vena cava. Pacing Clin Electrophysiol 2010 0.75
115 Destructive device removal - sparks and deletion of therapy history from an implantable cardioverter defibrillator. Int Heart J 2009 0.75
116 Mitral isthmus pathology of re-entrant ventricular tachycardia in a patient with idiopathic dilated cardiomyopathy. Europace 2009 0.75
117 Coexistence of the permanent form of junctional reciprocating tachycardia and atrial tachycardia. Circ J 2005 0.75
118 Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone. Pacing Clin Electrophysiol 2004 0.75
119 Stereoselective effect of amiodarone on the pharmacokinetics of racemic carvedilol. Drug Metab Pharmacokinet 2005 0.75
120 Pronounced Shortening of QT Interval With Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome. Circ J 2015 0.75
121 Abrupt heart rate fallings in a patient with biventricular pacing: latent risk for exacerbation of heart failure. Pacing Clin Electrophysiol 2010 0.75
122 Ventricular tachycardia with figure eight pattern originating from the right ventricle in a patient with cardiac sarcoidosis. Pacing Clin Electrophysiol 2004 0.75
123 Utility of High-Resolution Magnetocardiography to Predict Later Cardiac Events in Nonischemic Cardiomyopathy Patients With Normal QRS Duration. Circ J 2016 0.75
124 [Management of cardiovascular pre-symptomatic state in aged people--prevalence and prognosis of asymptomatic arrhythmias]. Nihon Ronen Igakkai Zasshi 2006 0.75
125 Successful slow pathway ablation in a patient with a rare unroofed type coronary sinus. Pacing Clin Electrophysiol 2012 0.75
126 Directions of atrial excitation wavefront influenced antegrade conduction of manifest accessory atrioventricular pathway: a case report. J Interv Card Electrophysiol 2003 0.75
127 Comparison of antiarrhythmics used in patients with paroxysmal atrial fibrillation: subanalysis of J-RHYTHM Study. Circ J 2009 0.75
128 Incessant monomorphic ventricular tachycardia induced by the proarrhythmic effect of amiodarone. Intern Med 2011 0.75
129 Diagnostic Value of Right Ventricular Dysfunction in Tachycardia-Induced Cardiomyopathy Using Cardiac Magnetic Resonance Imaging. Circ J 2016 0.75
130 [Establishment of a cut-off value for the diagnosis of acute myocardial infarction using a new CK-MB activity measurement reagent containing anti-MtCK antibody]. Rinsho Byori 2011 0.75
131 Pilsicainide-induced verapamil sensitive idiopathic left ventricular tachycardia. Pacing Clin Electrophysiol 2006 0.75
132 Assessment of ability of activation mapping by duodecapolar catheter to diagnose complete isthmus block utilizing electroanatomical mapping system. J Interv Card Electrophysiol 2006 0.75
133 Twelve novel single nucleotide polymorphisms in ABCB1/MDR1 among Japanese patients with ventricular tachycardia who were administered amiodarone. Drug Metab Pharmacokinet 2002 0.75
134 Novel single nucleotide polymorphisms in the CYP2D6 gene associated with CYP2D6*2 and/or CYP2D6*10 alleles. Drug Metab Pharmacokinet 2002 0.75
135 Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population. Biol Pharm Bull 2005 0.75
136 Comparison of the acute effects of right ventricular apical pacing and biventricular pacing in patients with heart failure. Intern Med 2015 0.75
137 Electrical space-time abnormalities of ventricular depolarization in patients with Brugada syndrome and patients with complete right-bundle branch blocks studied by magnetocardiography. Pacing Clin Electrophysiol 2006 0.75
138 Impact of drug alteration to maintain rhythm control in paroxysmal atrial fibrillation. - Subanalysis from J-RHYTHM study -. Circ J 2010 0.75
139 Site-specific influence of transversal conduction across crista terminalis on recognition of isthmus block. Pacing Clin Electrophysiol 2006 0.75
140 Anatomic assessment of variations in myocardial approaches to the atrioventricular node. J Cardiovasc Electrophysiol 2011 0.75
141 Single-Coil Defibrillator Leads Yield Satisfactory Defibrillation Safety Margin in Hypertrophic Cardiomyopathy. Circ J 2016 0.75
142 Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases. Circ J 2008 0.75
143 Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension. Circ J 2006 0.75
144 [Clinical care for patients with possible Brugada syndrome]. Nihon Naika Gakkai Zasshi 2006 0.75
145 Usefulness of scintigraphy to predict electrical storms in severe idiopathic dilated cardiomyopathy. Ann Nucl Med 2013 0.75
146 [Indication of implantable cardioverter defibrillator for heart failure]. Nihon Rinsho 2007 0.75
147 Change in morphology of reentrant atrial arrhythmias without termination following radiofrequency catheter ablation. Pacing Clin Electrophysiol 2002 0.75
148 Asystole caused by vegetation and abscess of right ventricle attached to a tip of pacemaker lead. Pacing Clin Electrophysiol 2008 0.75
149 Evaluation of mexiletine clearance in a Japanese population. Ann Pharmacother 2002 0.75
150 Long-term efficacy of empirical chronic amiodarone therapy in patients with sustained ventricular tachyarrhythmia and structural heart disease. Circ J 2002 0.75
151 Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease. Pacing Clin Electrophysiol 2015 0.75